Anatomical Measurement of the Masseter Muscle and Surface Mapping of the Maximal Thickness Point Using Computed Tomography Analysis

전산화단층촬영 영상분석을 이용한 교근의 해부학적 계측 및 최대 두께점 피부 표지화

  • Suh, Hyeun-Woo (Department of Plastic and Reconstructive Surgery, Bundang Jesaeng General Hospital) ;
  • Kim, Hyo-Seong (Department of Plastic and Reconstructive Surgery, Bundang Jesaeng General Hospital) ;
  • Ha, Ki-Young (Department of Plastic and Reconstructive Surgery, Bundang Jesaeng General Hospital) ;
  • Kim, Boo-Yeong (Department of Plastic and Reconstructive Surgery, Bundang Jesaeng General Hospital) ;
  • Pae, Nam-Seok (Department of Plastic and Reconstructive Surgery, Bundang Jesaeng General Hospital) ;
  • Kim, Tae-Yeon (Department of Plastic and Reconstructive Surgery, Bundang Jesaeng General Hospital)
  • 서현우 (분당제생병원 성형외과) ;
  • 김효성 (분당제생병원 성형외과) ;
  • 하기영 (분당제생병원 성형외과) ;
  • 김부영 (분당제생병원 성형외과) ;
  • 배남석 (분당제생병원 성형외과) ;
  • 김태연 (분당제생병원 성형외과)
  • Received : 2010.08.03
  • Accepted : 2010.12.28
  • Published : 2011.03.10

Abstract

Purpose: Masseter muscle is an important muscle of mastication. Because it has a great influence on the shape of low facial contour, patients who have masseteric hypertrophy show square-shaped jaw appearance. As aesthetic procedures for the reduction of the masseter muscle volume, radiofrequency ablation or botulinum toxin injection is at the center of attention. Authors studied the anatomical measurement of the thickness and width of masseter muscle and the surface mapping of the maximal thickness point using computed tomography (CT) scan to identify the useful guide for the injection of botulinum toxin in masseteric hypertrophy patients. Methods: We analyzed 2 mm-thickness OMU (ostiomeatal unit) CT of 112 normal people (224 masseter muscles) taken from June 2009 to May 2010. First, we measured the thickness, width and depth of the masseter muscle from the skin surface and analysed each by side, sex and age, respectively. The distribution of the thickness of the muscle and the correlation of thickness and width of the muscle were studied also. Second, we underwent surface mapping of the maximal thickness point using CT analysis by means of checking the vertical and horizontal distance from the angle of the mandible. Results: The average thickness and width of the masseter muscle was 17.73 mm and 40.78 mm in the male patients and were 14.33 mm and 37.42 mm in the female patients. Statistically, both figures of the male patients were larger than those of the female patients. However, the depth of the muscle from the skin surface in female patients (7.37 mm) was larger than that of the male patients (6.15 mm). There were no statistical difference in side or age. The width and thickness of the masseter muscle were in the positive correlation. The location of maximal thickness point of the masseter muscle was 27.77 mm vertically and 27.68 mm horizontally in the male patients, and 25.19 mm vertically and 25.42 mm horizontally in the female patients from the angle of mandible. Conclusion: We were able to present statistical evidence of the diagnosis and treatment of the masseteric hypertrophy regarding the anatomical measurements such as the thickness and width. And the maximal thickness point of the masseter muscle may be a useful guide for the clinical procedures of botulinum toxin injection.

Keywords

References

  1. Al-Muharraqi MA, Fedorowicz Z, Al Bareeq J, AL Bareeq R, Nasser M: Botulinum toxin for masseter hypertrophy. Cochrane Database Syst Rev 21: 1, 2009
  2. Moore AP, Wood GD: The medical management of masseteric hypertrophy with botulinum toxin type A. Br J Oral Maxillofac Surg 32: 26, 1994 https://doi.org/10.1016/0266-4356(94)90168-6
  3. Baek JH, Choi JW, Yoo SK, Kim YO, Park BY: Measurement method of the masseter muscle volume using 3D computed tomography. J Korean Soc Plast Reconstr Surg 32: 589, 2005
  4. Kim JH, Lee MJ, Kim HJ, Son DG, Han KH, Lee SY, Lim JG, Choi IJ: Surface mapping of masseter for botulinum toxin injection. J Korean Soc Plast Reconstr Surg 32: 311, 2005
  5. Chong VF, Fan YF, Lau D, Sethi DS: Pictorial review: Functional endoscopic sinus surgery: What radiologists need to know. Clin Radiol 53: 650, 1998 https://doi.org/10.1016/S0009-9260(98)80291-2
  6. Gurney CE: Chronic bilateral benign hypertrophy of the masseter muscles. Am J Surg 73: 137, 1947 https://doi.org/10.1016/0002-9610(47)90304-8
  7. Smyth AG: Botulinum toxin treatment of bilateral masseteric hypertrophy. Br J Oral Maxillofac Surg 32: 29, 1994 https://doi.org/10.1016/0266-4356(94)90169-4
  8. von Lindern JJ, Niederhagen B, Appel T, Berge S, Reich, RH: Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg 107: 327, 2001 https://doi.org/10.1097/00006534-200102000-00004
  9. Park MY, Ahn KY, Jung DS: Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg 29: 477, 2003 https://doi.org/10.1046/j.1524-4725.2003.29116.x
  10. Yoon HC: Botox use clinic. 1st ed, Busan, Mirae, 2002, p 183
  11. Carruthers JD, Glogau RG, Blitzer A, Facial Aesthetics Consensus Group Faculty: Advances in facial rejuvenation: Botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations. Plast Reconstr Surg 121: 5S, 2008 https://doi.org/10.1097/PRS.0b013e31816de8d0
  12. Xu JA, Yuasa K, Yoshiura K, Kanda S: Quantitative analysis of masticatory muscles using computed tomography. Dentomaxillofac Radiol 23: 154, 1994 https://doi.org/10.1259/dmfr.23.3.7835516